Rachel Harding

999 total citations
27 papers, 433 citations indexed

About

Rachel Harding is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rachel Harding has authored 27 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rachel Harding's work include Ubiquitin and proteasome pathways (9 papers), Genetic Neurodegenerative Diseases (8 papers) and Mitochondrial Function and Pathology (6 papers). Rachel Harding is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Genetic Neurodegenerative Diseases (8 papers) and Mitochondrial Function and Pathology (6 papers). Rachel Harding collaborates with scholars based in Canada, United States and United Kingdom. Rachel Harding's co-authors include Yufeng Tong, C.H. Arrowsmith, Matthieu Schapira, Renato Ferreira de Freitas, Ian W. Hamley, Ivan Franzoni, David Stewart, Corrie T. Imrie, Catherine Rémy and Mandeep Mann and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Journal of Materials Chemistry.

In The Last Decade

Rachel Harding

25 papers receiving 427 citations

Peers

Rachel Harding
Rachel Harding
Citations per year, relative to Rachel Harding Rachel Harding (= 1×) peers Jens Jacob Hansen

Countries citing papers authored by Rachel Harding

Since Specialization
Citations

This map shows the geographic impact of Rachel Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Harding more than expected).

Fields of papers citing papers by Rachel Harding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Harding. The network helps show where Rachel Harding may publish in the future.

Co-authorship network of co-authors of Rachel Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Harding. A scholar is included among the top collaborators of Rachel Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Harding. Rachel Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harding, Rachel, Yuanyun Xie, Nicholas S. Caron, et al.. (2025). Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification. Biomarker Research. 13(1). 63–63.
2.
Ridder, Jeroen de, Leentje Persoons, Steven De Jonghe, et al.. (2024). Synthesis and functional screening of novel inhibitors targeting the HDAC6 zinc finger ubiquitin-binding domain. European Journal of Medicinal Chemistry. 285. 117208–117208. 1 indexed citations
3.
Eguida, Merveille, Guillaume Bret, Fengling Li, et al.. (2024). Subpocket Similarity-Based Hit Identification for Challenging Targets: Application to the WDR Domain of LRRK2. Journal of Chemical Information and Modeling. 64(13). 5344–5355. 4 indexed citations
4.
Schapira, Matthieu, Levon Halabelian, C.H. Arrowsmith, & Rachel Harding. (2024). Big data and benchmarking initiatives to bridge the gap from AlphaFold to drug design. Nature Chemical Biology. 20(8). 937–940. 5 indexed citations
5.
Fan, Lixin, Rachel Harding, Panayiotis O. Vacratsis, et al.. (2024). Autoinhibition of ubiquitin-specific protease 8: Insights into domain interactions and mechanisms of regulation. Journal of Biological Chemistry. 300(10). 107727–107727. 2 indexed citations
6.
Harding, Rachel, Ivan Franzoni, Mandeep Mann, et al.. (2023). Discovery and characterization of a chemical probe targeting the zinc-finger ubiquitin-binding domain of HDAC6. Figshare. 1 indexed citations
7.
Harding, Rachel, Patrick Bermudez, Alexander Bernier, et al.. (2023). The Canadian Open Neuroscience Platform—An open science framework for the neuroscience community. PLoS Computational Biology. 19(7). e1011230–e1011230. 4 indexed citations
8.
Alteen, Matthew G., Justin C. Deme, P. Loppnau, et al.. (2023). Delineation of functional subdomains of Huntingtin protein and their interaction with HAP40. Structure. 31(9). 1121–1131.e6. 4 indexed citations
9.
Harding, Rachel, Ivan Franzoni, Mandeep Mann, et al.. (2023). Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6. Journal of Medicinal Chemistry. 66(15). 10273–10288. 7 indexed citations
10.
Mann, Mandeep, Brian J. Wilson, Albina Bolotokova, et al.. (2023). Small Molecule Screen Identifies Non-catalytic USP3 Chemical Handle. ACS Omega. 9(1). 917–924. 1 indexed citations
11.
Harding, Rachel, Justin C. Deme, Johannes F. Hevler, et al.. (2021). Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1. Communications Biology. 4(1). 1374–1374. 26 indexed citations
12.
Mann, Mandeep, Carlos Zepeda‐Velázquez, Aiping Dong, et al.. (2021). Structure–Activity Relationship of USP5 Inhibitors. Journal of Medicinal Chemistry. 64(20). 15017–15036. 13 indexed citations
13.
Harding, Rachel, P. Loppnau, Suzanne Ackloo, et al.. (2019). Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems. Journal of Biological Chemistry. 294(17). 6986–7001. 23 indexed citations
14.
Harding, Rachel. (2019). Open notebook science can maximize impact for rare disease projects. PLoS Biology. 17(1). e3000120–e3000120. 3 indexed citations
15.
Mann, Mandeep, Ivan Franzoni, Renato Ferreira de Freitas, et al.. (2019). Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain. Journal of Medicinal Chemistry. 62(22). 10144–10155. 10 indexed citations
16.
Freitas, Renato Ferreira de, Rachel Harding, Ivan Franzoni, et al.. (2018). Identification and Structure–Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors. Journal of Medicinal Chemistry. 61(10). 4517–4527. 50 indexed citations
17.
Harding, Rachel & Yufeng Tong. (2018). Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities. Acta Pharmacologica Sinica. 39(5). 754–769. 66 indexed citations
18.
Harding, Rachel, Renato Ferreira de Freitas, P.M. Collins, et al.. (2017). Small Molecule Antagonists of the Interaction between the Histone Deacetylase 6 Zinc-Finger Domain and Ubiquitin. Journal of Medicinal Chemistry. 60(21). 9090–9096. 29 indexed citations
19.
Zhang, Qi, Rachel Harding, Feng Hou, et al.. (2016). Structural Basis of the Recruitment of Ubiquitin-specific Protease USP15 by Spliceosome Recycling Factor SART3. Journal of Biological Chemistry. 291(33). 17283–17292. 21 indexed citations
20.
Johnson, Steven, Lionel Tan, Stijn van der Veen, et al.. (2012). Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules. PLoS Pathogens. 8(10). e1002981–e1002981. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026